Skip to main content

Covid-19 fight: Indian companies join race to develop blood products

As the development of vaccines or any drug will take time, research on Sars-CoV-2 neutralising antibodies is gaining ground to fill an unmet demand in therapy

from Today's Paper https://ift.tt/3cANjXw

Comments

Popular posts from this blog